Objectives of the Study. Summary of observational studies concerning the pharmacological management of diabetic macular edema (DME). Methods. A literature review was conducted using the PubMed database on 1 February 2018 to identify studies evaluating the efficacy of anti-VEGF and dexamethasone (DEX) implants for DME. Studies with more than 10 patients and follow-up of more than 6 months were selected. Analyses were carried out on the overall population and on subgroups defined according to baseline visual acuity (BVA) and the patients’ naïve or non-naïve status. Results. Thirty-two studies evaluating the efficacy of anti-VEGF and 31 studies evaluating the efficacy of DEX-implants were retained, concerning 6,842 and 1,703 eyes, respectively...
Zafer Cebeci, Nur KirDepartment of Ophthalmology, Istanbul Faculty of Medicine, Istanbul University,...
Abstract Background This meta-analysis evaluated the effectiveness and safety of dexamethasone (DEX)...
Mojca Urbančič,1 Ivana Gardašević Topčić21Eye Hospital, University Medical Centre Ljubljana, ...
Background Diabetic macular edema (DME) impairs vision and reduces the quality of life. Clinical tri...
Diabetic macular edema (DME) is a major sight-threatening cause in diabetic patients. The pathophysi...
AIM: To investigate the safety and efficacy of intravitreal dexamethasone implants (Ozurdex®/DEX) in...
SummaryDiabetic macular edema (DME) is a major cause of visual impairment in diabetic patients. Lase...
Objective: The study compares the effectiveness of an intravitreal slow-release dexamethasone implan...
PURPOSE: To evaluate the effects of intravitreal dexamethasone (DEX) implants in patients affected ...
Purpose: To evaluate the efficacy, effect profile, and safety of dexamethasone implant on diabetic m...
Purpose: To investigate efficacy and safety of repeated dexamethasone (DEX) implants over 24 months,...
Purpose: This meta-analysis aims to summarize 12-month best-corrected visual acuity (BCVA) outcomes ...
Diabetic macular edema (DME) represents a prevalent and disabling eye condition. Despite that DME re...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Aims To describe and compare the functional and anatomical outcomes of untreated and treated diabeti...
Zafer Cebeci, Nur KirDepartment of Ophthalmology, Istanbul Faculty of Medicine, Istanbul University,...
Abstract Background This meta-analysis evaluated the effectiveness and safety of dexamethasone (DEX)...
Mojca Urbančič,1 Ivana Gardašević Topčić21Eye Hospital, University Medical Centre Ljubljana, ...
Background Diabetic macular edema (DME) impairs vision and reduces the quality of life. Clinical tri...
Diabetic macular edema (DME) is a major sight-threatening cause in diabetic patients. The pathophysi...
AIM: To investigate the safety and efficacy of intravitreal dexamethasone implants (Ozurdex®/DEX) in...
SummaryDiabetic macular edema (DME) is a major cause of visual impairment in diabetic patients. Lase...
Objective: The study compares the effectiveness of an intravitreal slow-release dexamethasone implan...
PURPOSE: To evaluate the effects of intravitreal dexamethasone (DEX) implants in patients affected ...
Purpose: To evaluate the efficacy, effect profile, and safety of dexamethasone implant on diabetic m...
Purpose: To investigate efficacy and safety of repeated dexamethasone (DEX) implants over 24 months,...
Purpose: This meta-analysis aims to summarize 12-month best-corrected visual acuity (BCVA) outcomes ...
Diabetic macular edema (DME) represents a prevalent and disabling eye condition. Despite that DME re...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Aims To describe and compare the functional and anatomical outcomes of untreated and treated diabeti...
Zafer Cebeci, Nur KirDepartment of Ophthalmology, Istanbul Faculty of Medicine, Istanbul University,...
Abstract Background This meta-analysis evaluated the effectiveness and safety of dexamethasone (DEX)...
Mojca Urbančič,1 Ivana Gardašević Topčić21Eye Hospital, University Medical Centre Ljubljana, ...